Sun X, Eastman G, Shi Y, et al
It's important to note that Ozempic is currently only FDA-approved for to treat Type 2 diabetes and to treat chronic kidney disease in diabetic patients
And it's become increasingly popular because it's truly the biggest breakthrough in medical weight loss options we've ever seen
Effect of Liraglutide on Body Weight in Non-Diabetic Obese Subjects or Overweight Subjects With Co-Morbidities: SCALE-Obesity and Pre-Diabetes (2011)
Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, is in clinical trials and will add another option for patients who do not tolerate existing medications
However, they are not registered dietitians, licensed nutritionists, or medical professionals